Hazard Hub

Product quality Recalls in Canada — Page 5

340 recalls involving product quality — most are health products recalls. Newest first, updated daily from government open data.

Showing 121–150 of 340

Health Products Type III
2025-03-19

All Clean Ultra Disinfectant Wipes: An active ingredient may not be present

Product quality

View recall details →

Health Products Type III
2025-03-18

All Clean Natural Sanitizing Wipes: Undeclared ingredients

Product quality

View recall details →

Health Products Type III
2025-03-11

Jamp Calcium Carbonate 500 + Vitamin D 1000 Tablet; Out of Specification (Dissolution)

Product quality

View recall details →

Health Products Type II
2025-03-06

Jamp K8 Tablet; Out of Specification (Dissolution)

Product quality

View recall details →

Health Products Type II
2025-03-06

L-Theanine 250 mg capsule; Out of specification (Microbial, Yeast & Mold count)

Product quality

View recall details →

Health Products Type III
2025-03-05

RespirActin Deep Lung Cleanse Capsule; Do not contain medicinal ingredient listed on the label

Product quality

View recall details →

Health Products Type III
2025-03-03

Jamp Itraconazole Oral Solution: Presence of crystalline particles

Product quality

View recall details →

Health Products Type II
2025-03-03

Medline Alcohol Prep Pad: 70% Isopropyl Alcohol: No Market Authorization

Product quality

View recall details →

Health Products Type II
2025-02-18

BD ChloraPrep™ Clear: Affected lot may contain the presence of Aspergillus penicilloides

Product quality

View recall details →

Health Products Type III
2025-02-18

CISATRACURIUM BESYLATE INJECTION USP MULTIDOSE: The level of the degradation product Benzaldehyde is out of specification in the affected lots.

Product quality

View recall details →

Health Products Type II
2025-02-06

BIOV Health Calcium (Carbonate) recall due to deficiencies in Good Manufacturing Practices (GMP)

Product quality

View recall details →

Health Products Type I
2025-02-03

Lacosamide 10mg/ml : Presence of particulate matter in affected lot.

Product quality

View recall details →

Health Products Type I
2025-01-31

APO-QUETIAPINE XR - May exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP).

Product quality

View recall details →

Health Products Type II
2025-01-31

PMS-FLUOXETINE 10 mg - May contain capsules of PMS-Fluoxetine 20mg.

Product quality

View recall details →

Health Products Type I
2025-01-21

Semaglutide + Pyridoxine: produced with an unauthorized active pharmaceutical ingredient

Product quality

View recall details →

Health Products Type II
2025-01-13

AG-Escitalopram: may contain blisters of the foreign product Tillomed Gabapentin 100mg capsule

Product quality

View recall details →

Health Products Type II
2025-01-07

JAMP-Escitalopram: may contain blisters of the foreign product Tillomed Gabapentin 100mg capsule

Product quality

View recall details →

Health Products Type I
2025-01-07

QUETIAPINE XR : Affected lots may exceed the established acceptable intake limit for N-nitroso-desalkyl-quetiapine (NNAP)

Product quality

View recall details →

Health Products Type II
2024-12-23

Jamp Amoxi Clav Suspension; Out of specification

Product quality

View recall details →

Health Products Type II
2024-12-06

Absorbine Jr. Extra Strength Multi Use Patch: Voluntary recall due to significant violations to the GMPs

Product quality

View recall details →

Health Products Type II
2024-11-29

Florabile: The total combined yeasts and molds count may be out of specification for the affected lots.

Product quality

View recall details →

Health Products Type II
2024-11-19

Pregabalin: Affected lot may contain partially full or empty capsules.

Product quality - Product safety

View recall details →

Health Products Type II
2024-11-14

JAMP-FeR: Yeasts and molds count is out of specification

Product quality

View recall details →

Health Products Type II
2024-11-14

PMS-PREGABALIN: Affected lot may contain empty capsules.

Product quality - Product safety

View recall details →

Health Products Type III
2024-11-13

Actifungi Cream: Affected batches do not comply with the conditions of the product marketing authorization.

Product quality

View recall details →

Health Products Type I
2024-11-08

Titanium 4000, Titanium 4000+: undeclared ingredient sildenafil.

Product quality - Unauthorized product

View recall details →

Health Products Type II
2024-11-05

COMPLETE 6000 WIPES: Out-of-specification (Sodium Hypochlorite content)

Product quality

View recall details →

Health Products Type II
2024-11-04

Florabile: Out of Specification

Product quality

View recall details →

Health Products Type II
2024-10-15

Jamp-Finasteride tablet; Out-of-specification (Finasteride content)

Product quality

View recall details →

Health Products Type II
2024-10-11

Stress-B-Plus Tablet: Contains Niacin instead of Niacinamide

Product quality

View recall details →

Other Health Products Hazards

COVID (279)Labelling (73)Contamination (61)Packaging (45)

Browse all recalls by hazard, allergen & year →